Evaluation of the Roche Elecsys Toxo IgG and IgM electrochemiluminescence immunoassay for the detection of gestational Toxoplasma infection

Diagnostic Microbiology and Infectious Disease

Volumn 68, Issue 4, 2010, Pages 352-357

  Prusa, Andrea Romana ^a   Hayde, Michael ^a   Unterasinger, Lukas ^a   Pollak, Arnold ^a   Herkner, Kurt R ^a,b   Kasper, David C ^a,b  

^a UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Congenital toxoplasmosis; Gestational infection; Serologic screening; Toxoplasma gondii

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHYLENE BLUE;

ADULT; AGGLUTINATION TEST; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTROCHEMILUMINESCENCE IMMUNOASSAY; FEMALE; GESTATION PERIOD; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PREDICTION; PREGNANCY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ACUTE DISEASE; ANIMALS; ANTIBODIES, PROTOZOAN; CHEMILUMINESCENT MEASUREMENTS; CHRONIC DISEASE; ELECTROCHEMISTRY; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; TOXOPLASMA; TOXOPLASMOSIS;

EID: 78649291150     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.07.011     Document Type: Article

References (26)

1. Aspock H., Husslein P., et al. Toxoplasmosis. Recommendations for treatment of primary toxoplasma infection in pregnancy and congenital toxoplasmosis. Gynakol. Geburtshilfliche Rundsch. 1994, 34:50-51.
2. Carlier Y., Bout D., et al. Evaluation of the enzyme-linked immunosorbent assay (ELISA) and other serological tests for the diagnosis of toxoplasmosis. Bull. World. Health. Organ. 1980, 58:99-105.
3. Desmonts G., Naot Y., et al. Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired toxoplasma infections. J. Clin. Microbiol. 1981, 14:486-491.
4. Duffy K.T., Wharton P.J., et al. Assessment of immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM. J. Clin. Pathol. 1989, 42:1291-1295.
5. Freeman K., Salt A., et al. Association between congenital toxoplasmosis and parent-reported developmental outcomes, concerns, and impairments, in 3 year old children. BMC Pediatr. 2005, 5:23.
6. Gras L., Gilbert R.E., et al. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol. Infect. 2004, 132:541-548.
7. Gras L., Wallon M., et al. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta. Paediatr. 2005, 94:1721-1731.
8. Gratzl R., Hayde M., et al. Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid. Eur. J. Clin. Microbiol. Infect. Dis. 1998, 17:853-858.
9. Hayde M., Salzer H.R., et al. Microparticle enzyme immunoassay (MEIA) for toxoplasma specific immunoglobulin G in comparison to the Sabin-Feldman dye test. A pilot study. Wien. Klin. Wochenschr. 1995, 107:133-136.
10. Kasper D.C., Prusa A.R., et al. Evaluation of the Vitros ECiQ immunodiagnostic system for detection of anti-toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women. J. Clin. Microbiol. 2009, 47:164-167.
11. Kasper D.C., Sadeghi K., et al. Quantitative real-time polymerase chain reaction for the accurate detection of Toxoplasma gondii in amniotic fluid. Diagn. Microbiol. Infect. Dis. 2009, 63:10-15.
12. Kieffer F., Wallon M., et al. Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr. Infect. Dis. J. 2008, 27:27-32.
13. Knerer B., Hayde M., et al. Direct detection of Toxoplasma gondii with polymerase chain reaction in diagnosis of fetal toxoplasma infection. Wien. Klin. Wochenschr. 1995, 107:137-140.
14. Lebech M., Joynson D.H., et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 1996, 15:799-805.
15. Meek B., van Gool T., et al. Dissecting the IgM antibody response during the acute and latent phase of toxoplasmosis. Diagn. Microbiol. Infect. Dis. 2001, 41:131-137.
16. Meroni V., Genco F., et al. Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies. Clin. Vaccine Immunol. 2009, 16:1517-1520.
17. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363:1965-1976.
18. Naot Y., Remington J.S. An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis. J. Infect. Dis. 1980, 142:757-766.
19. Petersen E., Borobio M.V., et al. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J. Clin. Microbiol. 2005, 43:1570-1574.
20. Press C., Montoya J.G., et al. Use of a single serum sample for diagnosis of acute toxoplasmosis in pregnant women and other adults. J. Clin. Microbiol. 2005, 43:3481-3483.
21. Reiter-Owona I., Petersen E., et al. The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis. Bull. World Health Organ. 1999, 77:929-935.
22. Remington J.S., McLeod R., Thulliez P., Desmonts G. Toxoplasmosis. Infectious diseases of the fetus and newborn infant 2000, 205-346. W. B. Saunders Company, Philadelphia. 5th. J.S. Remington, J.O. Klein (Eds.).
23. Sabin A.B., Feldman H.A. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoan parasite (Toxoplasma). Science 1948, 108:660-663.
24. Sickinger E., Braun H.B., et al. Evaluation of the Abbott ARCHITECT Toxo IgM assay. Diagn. Microbiol. Infect. Dis. 2009, 64:275-282.
25. Thiebaut R., Leproust S., et al. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 2007, 369:115-122.
26. Wilson C.B., Remington J.S., et al. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980, 66:767-774.